Skip to main content
Market intelligence
PFEHealthcare

Pfizer Inc. insider activity

In the last 90 days, 3 corporate insiders purchased $2,960,110 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$2,960,110
Corporate buyers
3
Latest transaction
Aug 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 12, 2026Albert BourlaChairman & CEOOpen Market Purchase38,000$26.34$1,000,920
Aug 5, 2026Jennifer B. DamicoSVP & ControllerSale3,278$25.40$83,261
Aug 5, 2026Ronald E BlaylockCorporate insiderOpen Market Purchase39,231$25.46$998,821